Cargando…

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling. However, the underlying regulatory mechanism remains to be elucidated. Here we identified a heart-enriched long non-coding (lnc)RNA, named Cardiac Hypertrophy Associated Epigeneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhihua, Zhang, Xiao-Jing, Ji, Yan-Xiao, Zhang, Peng, Deng, Ke-Qiong, Gong, Jun, Ren, Shuxun, Wang, Xinghua, Chen, Iris, Wang, He, Gao, Chen, Yokota, Tomohiro, Ang, Yen Sin, Li, Shen, Cass, Ashley, Vondriska, Thomas M., Li, Guangping, Deb, Arjun, Srivastava, Deepak, Yang, Huang-Tian, Xiao, Xinshu, Li, Hongliang, Wang, Yibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053883/ https://www.ncbi.nlm.nih.gov/pubmed/27618650 http://dx.doi.org/10.1038/nm.4179

Ejemplares similares

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

IRE1 Phosphatase PP2Ce Regulates Adaptive ER Stress Response in the Postpartum Mammary Gland
por: Ren, Shuxun, et al.
Publicado: (2014)

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure
por: Santolini, Marc, et al.
Publicado: (2018)

Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture
por: McKinsey, Timothy A., et al.
Publicado: (2018)

Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart
por: Chapski, Douglas J., et al.
Publicado: (2021)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

Tripartite motif 32 prevents pathological cardiac hypertrophy
por: Chen, Lijuan, et al.
Publicado: (2016)

Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1–3
por: Wang, Cheng-jun, et al.
Publicado: (2014)

Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
por: Yang, Hui, et al.
Publicado: (2020)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Catabolism of Branched-Chain Amino Acids in Heart Failure: Insights from Genetic Models
por: Sun, Haipeng, et al.
Publicado: (2011)

High triiodothyronine levels induce myocardial hypertrophy via BAFF overexpression
por: Li, Guo‐Qing, et al.
Publicado: (2022)

Revisional Endoscopic Foraminal Decompression via Modified Interlaminar Approach at L5-S1 after Failed Posterior Instrumented Lumbar Fusion in Elderly Patients
por: Cao, Zheng, et al.
Publicado: (2023)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Intronic Splicing Enhancers, Cognate Splicing Factors and Context Dependent Regulation Rules
por: Wang, Yang, et al.
Publicado: (2012)

DES mutation associated with cardiac hypertrophy and alternating bundle branch block
por: Chen, Ru, et al.
Publicado: (2020)

Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy
por: Gao, Maomao, et al.
Publicado: (2020)

NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
por: Guo, Ningning, et al.
Publicado: (2021)

Serum complement C1q level is associated with left ventricular hypertrophy induced by coarctation of the aorta: A retrospective observational study
por: Chen, Li, et al.
Publicado: (2022)

Multimodality imaging in diagnosing lipomatous atrial septal hypertrophy with atrial septal defect: a case report
por: Yu, Yi, et al.
Publicado: (2023)

Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus
por: Lu, Qi-Lin, et al.
Publicado: (2020)

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy
por: Han, Sha-sha, et al.
Publicado: (2015)

Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis
por: Bian, Zhouyan, et al.
Publicado: (2009)

Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy
por: An, Xiangbo, et al.
Publicado: (2016)

A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy
por: Cai, Jingjing, et al.
Publicado: (2019)

Genomewide Identification and Characterization of the Genes Involved in the Flowering of Cotton
por: Li, Xiao, et al.
Publicado: (2022)

Catheter-Based Radiofrequency Renal Sympathetic Denervation Decreases Left Ventricular Hypertrophy in Hypertensive Dogs
por: Tu, Shan, et al.
Publicado: (2021)

Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018)

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
por: Wang, Jian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_igo0ad9f0nrf411e7d14efh2kc